Biologically Defined Neuronal Synuclein Disease As a Tool to Advance Drug Development

Overview

Journal NPJ Parkinsons Dis

Date 2024 Dec 20

PMID 39706882

Authors

Gennaro Pagano

Tien Dam

Geoffrey A Kerchner

Wendy R Galpern

Milton Biagioni

Rajesh Karan

Danna Jennings

M Judith Peterschmitt

Tania Nikolcheva

Patrik Brundin

Affiliations

Soon will be listed here.

References

Ji Z, Chen Q, Yang J, Hou J, Wu H, Zhang L . Global, regional, and national health inequalities of Alzheimer's disease and Parkinson's disease in 204 countries, 1990-2019. Int J Equity Health. 2024; 23(1):125. PMC: 11188225. DOI: 10.1186/s12939-024-02212-5. View

Schiess N, Cataldi R, Okun M, Fothergill-Misbah N, Ray Dorsey E, Bloem B . Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority. JAMA Neurol. 2022; 79(9):929-936. DOI: 10.1001/jamaneurol.2022.1783. View

Smith L, Schapira A . Variants and Parkinson Disease: Mechanisms and Treatments. Cells. 2022; 11(8). PMC: 9029385. DOI: 10.3390/cells11081261. View

Outeiro T, Alcalay R, Antonini A, Attems J, Bonifati V, Cardoso F . Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease". Mov Disord. 2023; 38(7):1127-1142. DOI: 10.1002/mds.29419. View

Maclagan L, Marras C, Sewell I, Wu C, Butt D, Tu K . Trends in health service use among persons with Parkinson's disease by rurality: A population-based repeated cross-sectional study. PLoS One. 2023; 18(5):e0285585. PMC: 10198504. DOI: 10.1371/journal.pone.0285585. View

Borghammer P, Okkels N, Weintraub D . Parkinson's Disease and Dementia with Lewy Bodies: One and the Same. J Parkinsons Dis. 2024; 14(3):383-397. PMC: 11091584. DOI: 10.3233/JPD-240002. View

Koga S, Sekiya H, Kondru N, Ross O, Dickson D . Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener. 2021; 16(1):83. PMC: 8684287. DOI: 10.1186/s13024-021-00501-z. View

Chen M, Wu R . LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review. J Biomed Sci. 2018; 25(1):52. PMC: 6000924. DOI: 10.1186/s12929-018-0454-0. View

Hillerstrom H, Fisher R, Janicki M, Chicoine B, Christian B, Esbensen A . Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome. Alzheimers Dement. 2024; 20(5):3649-3656. PMC: 11095423. DOI: 10.1002/alz.13778. View

10.

Simuni T, Chahine L, Poston K, Brumm M, Buracchio T, Campbell M . A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 2024; 23(2):178-190. DOI: 10.1016/S1474-4422(23)00405-2. View

11.

Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici G . The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review. J Nucl Med. 2022; 63(Suppl 1):13S-19S. PMC: 9165727. DOI: 10.2967/jnumed.121.263195. View

12.

Schindler S, Galasko D, Pereira A, Rabinovici G, Salloway S, Suarez-Calvet M . Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease. Nat Rev Neurol. 2024; 20(7):426-439. DOI: 10.1038/s41582-024-00977-5. View

13.

Jellinger K, Korczyn A . Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?. BMC Med. 2018; 16(1):34. PMC: 5840831. DOI: 10.1186/s12916-018-1016-8. View

14.

Chahine L, Merchant K, Siderowf A, Sherer T, Tanner C, Marek K . Proposal for a Biologic Staging System of Parkinson's Disease. J Parkinsons Dis. 2023; 13(3):297-309. PMC: 10200239. DOI: 10.3233/JPD-225111. View

15.

Hoglinger G, Adler C, Berg D, Klein C, Outeiro T, Poewe W . A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 2024; 23(2):191-204. DOI: 10.1016/S1474-4422(23)00404-0. View

16.

Gibbons C, Levine T, Adler C, Bellaire B, Wang N, Stohl J . Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies. JAMA. 2024; 331(15):1298-1306. PMC: 10955354. DOI: 10.1001/jama.2024.0792. View

17.

Okubadejo N, Okun M, Jankovic J . Tapping the Brakes on New Parkinson Disease Biological Staging. JAMA Neurol. 2024; 81(8):789-790. DOI: 10.1001/jamaneurol.2024.2054. View